Publications by authors named "Seema Parte"

Claim this Profile
O
Oncogenic potential of truncated-Gli3 via the Gsk3β/Gli3/AR-V7 axis in castration-resistant prostate cancer.
Jyoti B Kaushal, Pratima Raut, Sushanta Halder, Zahraa W Alsafwani, Seema Parte

Oncogene· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Altered metabolic traits in gastrointestinal tract cancers.
Seema Parte, Ramesh Pothuraju, Ranjith Kumavath, Rakesh Bhatia, Rama Krishna Nimmakayala

Front Endocrinol (Lausanne)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.
Seema Parte, Annant B Kaur, Rama Krishna Nimmakayala, Ayoola O Ogunleye, Ramakanth Chirravuri

Gastroenterology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3.
Hiren Patel, Deepa Bhartiya, Seema Parte, Pranesh Gunjal, Snehal Yedurkar

J Ovarian Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Further characterization of adult sheep ovarian stem cells and their involvement in neo-oogenesis and follicle assembly.
Hiren Patel, Deepa Bhartiya, Seema Parte

J Ovarian Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
Sanchita Rauth, Koelina Ganguly, Pranita Atri, Seema Parte, Rama Krishna Nimmakayala

Cell Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma.
Chunmeng Zhang, Pranita Atri, Palanisamy Nallasamy, Seema Parte, Sanchita Rauth

Cancer Lett· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Seema Parte, Abhirup C Are, Surinder K Batra

Mol Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
Imayavaramban Lakshmanan, Saravanakumar Marimuthu, Sanjib Chaudhary, Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Seema Parte

Oncogene· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer.
Rama Krishna Nimmakayala, Ayoola O Ogunleye, Seema Parte, Nivedeta Krishna Kumar, Pratima Raut

Cell Death Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
Sushanta Halder, Seema Parte, Prakash Kshirsagar, Sakthivel Muniyan, Hareesh B Nair

Biochim Biophys Acta Rev Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A p130Cas-Mediated Mechanism Governs Acinar to Ductal Metaplasia and the Initiation of Pancreatic Ductal Adenocarcinoma.
Rama Krishna Nimmakayala, Seema Parte, Surinder K Batra, Moorthy P Ponnusamy

Gastroenterology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma.
Seema Parte, Rama Krishna Nimmakayala, Surinder K Batra, Moorthy P Ponnusamy

Biochim Biophys Acta Rev Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.
Sarama Saha, Seema Parte, Partha Roy, Sham S Kakar

Adv Exp Med Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling.
Sakthivel Muniyan, Satyanarayana Rachagani, Seema Parte, Sushanta Halder, Parthasarathy Seshacharyulu

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
Sham S Kakar, Seema Parte, Kelsey Carter, Irving G Joshua, Christopher Worth

Oncotarget· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cells in Ovarian Cancer and Potential Therapies.
Elena Zuber, Diana Schweitzer, Dominick Allen, Seema Parte, Sham S Kakar

Proc Stem Cell Res Oncog· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.
Seema Parte, Irma Virant-Klun, Manish Patankar, Surinder K Batra, Alex Straughn

Stem Cell Rev Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.
Karen Udoh, Seema Parte, Kelsey Carter, Aaron Mack, Sham S Kakar

Stem Cell Rev Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
Seema C Parte, Surinder K Batra, Sham S Kakar

J Ovarian Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved understanding of very small embryonic-like stem cells in adult mammalian ovary.
Deepa Bhartiya, Hiren Patel, Seema Parte

Hum Reprod· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further characterization of adult sheep ovarian stem cells and their involvement in neo-oogenesis and follicle assembly.
Hiren Patel, Deepa Bhartiya, Seema Parte

J Ovarian Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
Seema C Parte, Andrei Smolenkov, Surinder K Batra, Mariusz Z Ratajczak, Sham S Kakar

Stem Cells Dev· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making gametes from alternate sources of stem cells: past, present and future.
Deepa Bhartiya, Sandhya Anand, Hiren Patel, Seema Parte

Reprod Biol Endocrinol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
Sham S Kakar, Seema Parte, Kelsey Carter, Irving G Joshua, Christopher Worth

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis